Meds

FDA delays could end vital treatment for rare disease patients

Meds
July 11, 2025

The FDA is failing rare disease patients. I’m one of them.

I’ve been on elamipretide for three years now. It is the only treatment that has made a meaningful difference in my life with primary mitochondrial myopathy—a degenerative genetic condition that impairs how my cells convert food and oxygen into energy. Mitochondria provide over 90 percent of the energy our bodies need; when they fail, the highest-demand tissues—like muscle, brain, and …

Read more…

Pharmacists are key to expanding Medicaid access to digital therapeutics

Meds
July 11, 2025

More than 78 million Americans rely on Medicaid or CHIP for their health care. Yet many still cannot access FDA-approved digital therapeutics because their state does not include them in covered benefits.

Prescription digital therapeutics (PDTs) are software-based treatments authorized by the FDA. They are delivered through smartphones or tablets and are used to manage conditions such as substance use disorder, ADHD, diabetes, and chronic insomnia. For people who face long …

Read more…

How medicine repurposing enables value-based pain management and insomnia therapy

Meds
July 8, 2025

In today’s evolving health care environment, value-based care is reshaping the future of medicine. The push toward value-based care demands innovative, cost-effective, and patient-centered solutions. A promising yet underutilized strategy is medicine repurposing, the practice of using existing medicines for new therapeutic purposes. Drug repurposing provides a strategic pathway to improving health outcomes while minimizing costs. A compelling example of this approach is the use of clonidine, a long-established cardiovascular …

Read more…

Forced voicemail and diagnosis codes are endangering patient access to medications

Meds
July 8, 2025

I won’t be using CVS pharmacies anymore. Sure, I may still need to send prescriptions their way as a physician—but as a consumer, I’m done.

Why?

CVS has recently implemented a new phone system that forces callers to leave a voicemail instead of waiting on hold. The idea is to streamline operations, letting pharmacy staff return calls when they have time. It’s supposed to manage call volume, reduce wait times, and shield …

Read more…

From stigma to science: Rethinking the U.S. drug scheduling system

Meds
July 3, 2025

In 1971, President Nixon initiated a battle that would reshape the United States: The War on Drugs. As a key part of that campaign, he enacted the Controlled Substances Act (CSA), which authorized the Drug Enforcement Administration (DEA) to categorize modern-day controlled substances into 5 “schedules” based on their “medical use, potential for abuse, and safety or dependence liability.” They range from Schedule I, which are substances with no …

Read more…

How drugmakers manipulate your health from diagnosis to prescription

Meds
June 27, 2025

It is said that 57 percent of U.S. doctors receive drugmaker/industry funding and 66 percent of U.S. adults are now on prescription drugs. Any correlation?

Drug ads now cast such a wide “symptom net,” comedian Chris Rock said he expected to hear, “Do you fall asleep at night and wake up in the morning? You might be suffering from ….”

Here are six ways drugmakers hijack U.S. medicine

Diagnosing. Once upon a time …

Read more…

The food-drug interaction risks your doctor may be missing

Meds
June 24, 2025

As a health care professional, I’ve often observed how one critical aspect of medication safety and efficacy gets overlooked: food-drug interactions.

Every day, we prescribe and dispense powerful medications — but what patients eat alongside those medications can completely alter their effects.

This isn’t just a pharmacy concern. It’s a multidisciplinary issue that deserves greater attention from physicians, pharmacists, and patient educators.

The physician’s role: Asking the right questions

We often do a solid …

Read more…

Why retail pharmacies are the future of diverse clinical trials

Meds
June 10, 2025

The importance of diversity in clinical trials is well-documented, yet unfortunately the lack of diversity still occurs at an alarming rate. As a result, we continue to have less effective treatments, poorer health outcomes, one-size-fits-all medicine that falls short of many patients, and many more negative impacts on health care.

The reason for lack of diversity in clinical trials is similarly known, with language barriers, limited access to health care facilities …

Read more…

Why does rifaximin cost 95 percent more in the U.S. than in Asia?

Meds
May 28, 2025

Rifaximin, a minimally absorbed antibiotic, has become a cornerstone therapy for several gastrointestinal disorders, including irritable bowel syndrome with diarrhea (IBS-D) and hepatic encephalopathy. Despite its established use, access to rifaximin varies significantly across global markets, with cost barriers posing challenges in some regions. In contrast, in many Asian countries, the same medication is available at a fraction of the price, raising important questions about pharmaceutical pricing practices and access …

Read more…

A world without antidepressants: What could possibly go wrong?

Meds
May 9, 2025

Imagine waking up one morning to a bold headline screaming: “New Global Law: All Antidepressants Abolished!” Just like that, no more Prozac, no more Zoloft—no more of those little pills that have helped millions keep their balance while navigating life’s emotional tightrope. Pharmacy shelves are wiped clean overnight, and suddenly, one of the pillars of modern mental health care is gone.

Before you clutch your chest and start breathing into a …

Read more…

The truth about GLP-1 medications for weight loss: What every patient should know

Meds
May 9, 2025

For years, weight loss has been sold as a simple math problem: eat less, move more, and the pounds will melt away. But if that were true, we wouldn’t have an obesity epidemic affecting over 40 percent of adults in the U.S.

Now, a new class of medications—GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound)—are changing the game. People who have struggled with their weight for …

Read more…

The hidden bias in how we treat chronic pain

Meds
May 2, 2025

As a health care writer and data analyst, I hear frequently from patients who are being denied safe and effective pain care due to unscientific bias on the part of U.S. health care agencies—and sometimes on the part of otherwise once-reputable medical journals. These are among millions of U.S. citizens who are now being deserted by the medical profession.

Thousands, overcome by their pain and depression, have already …

Read more…

Biologics are not small molecules: the case for pre-allergy testing in an era of immune-based therapies

Meds
May 1, 2025

“Once it’s in your body, there’s no taking it back.”

That’s what the infusion nurse told a friend of mine after administering the injection.

She had just started a biologic medication for an autoimmune condition. Immediately, her body reacted: nausea, then hives, then a terrifying tightening of her throat. She rushed back to the clinic. The IV steroids and Benadryl may have stopped the immediate effects, …

Read more…

ADVERTISEMENT

The anesthesia spectrum: Guiding patients through comfort options in oral surgery

Meds
April 30, 2025

“Will I be asleep or awake during my procedure?” This is the first question many patients ask before oral surgery. It reveals a common misconception: That anesthesia works like a light switch.

It doesn’t.

Anesthesia exists on a spectrum with multiple options that can be tailored to your specific needs, procedure type, and anxiety level.

Beyond all-or-nothing

As an oral …

Read more…

Functional precision oncology: a game changer in cancer therapy

Meds
April 22, 2025

Functional precision oncology is taking precision medicine to the next level. It is changing the way we fight cancer by testing a patient’s live tumor outside the body to determine the treatments most likely to work. This approach promises to double cancer response rates, improve survival, and reduce costs. It’s personal, data-driven, and long overdue, yet most cancer centers still don’t offer it.

Even many doctors are unaware that the standard …

Read more…

Why prescribing medicine to kids scares even experienced doctors

Meds
April 19, 2025

I absolutely hate prescribing medication to children.

I am quite worried when someone asks for my opinion on a sick child. I have some experience treating children during my internship and residency, yet I am pretty uncomfortable.

However, living in a lower middle-income country, where the average man already lives a difficult life due to high health care costs and limited income, health expenditure significantly impacts monthly finances. That is why people …

Read more…

Why long-acting injectables are transforming schizophrenia care

Meds
April 16, 2025

In recent years, psychiatric care has undergone a shift in the clinical mindset toward medication management for people living with schizophrenia and other chronic mental health conditions. As recognition grows for the breadth and depth of the clinical complexities and psychosocial challenges that patients may face along their diagnostic and treatment journey, there is movement toward ensuring that patients have access to treatment options that integrate their needs and preferences. …

Read more…

How America became overmedicated—and what we can do about it

Meds
April 6, 2025

In a revealing snapshot of American mental health, the CDC recently reported that nearly 1 in 4 adults in the United States may be taking psychotropic medications. This staggering number should both draw attention and raise questions. Are we truly addressing the root causes of psychiatric illness, or are we sedating a nation in pain?

As a psychiatrist and internist who has worked at the intersection of …

Read more…

The FDA’s outdated prescription rules are failing women and opioid users

Meds
March 25, 2025

An excerpt from Your Body, Your Health Care.

Tens of millions of American women—more than four out of five women who have had sexual intercourse—have used oral contraceptives, which are crucial for reducing unwanted pregnancies and the incidence of abortion. Obtaining a physician’s prescription can add up to $200 plus time and inconvenience to the cost of “the pill.” Nearly a third of American women who seek prescriptions for oral …

Read more…

Big pharma’s grip on health care: time for change

Meds
March 25, 2025

Everyone seems so scared of the word government regulation when it comes to health care. Why? In part, this is because those against regulations (everyone making money off health care) make sure to scare laypeople into equating such action with socialism. Fear of concept is not a good argument against regulating monopolies that are bankrupting millions of Americans. Pretty sure most Americans would be happy to have limitations placed on …

Read more…

17
pages